QS Investors’s Prestige Consumer Healthcare PBH Stock Holding History

QS Investors’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,200	Closed	-$46K	–	1441
2020 Q2	$46K	Sell	1,200 -4,400	-79%	-$176K	﹤0.01%	1460
2020 Q1	$206K	Buy	+5,600	New	+$217K	﹤0.01%	1057
2018 Q1	–	Sell	-1,100	Closed	-$49K	–	1981
2017 Q4	$49K	Hold	1,100	–	–	﹤0.01%	1491
2017 Q3	$55K	Sell	1,100 -6	-0.5%	-$307	﹤0.01%	1504
2017 Q2	$58K	Hold	1,106	–	–	﹤0.01%	1480
2017 Q1	$61K	Buy	1,106 +1,100	+18,333%	+$60.7K	﹤0.01%	1463
2016 Q4	$1K	Hold	6	–	–	﹤0.01%	1700
2016 Q3	$1K	Hold	6	–	–	﹤0.01%	1688
2016 Q2	$1K	Sell	6 -71,376	-100%	-$3.93M	﹤0.01%	1734
2016 Q1	$3.81M	Sell	71,382 -44,843	-39%	-$2.21M	0.04%	477
2015 Q4	$5.98M	Sell	116,225 -3,404	-3%	-$169K	0.06%	323
2015 Q3	$5.4M	Sell	119,629 -2,700	-2%	-$128K	0.06%	326
2015 Q2	$5.66M	Hold	122,329	–	–	0.07%	341
2015 Q1	$5.25M	Sell	122,329 -19,635	-14%	-$748K	0.06%	360
2014 Q4	$4.93M	Buy	+141,964	New	+$4.71M	0.06%	353

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

QS Investors's PBH Position: Q3 2020 in Review

QS Investors sold out of Prestige Consumer Healthcare (PBH) in Q3 2020, closing a stake of 1,200 shares — an estimated $46K sold.

QS Investors first reported a position in PBH in Q4 2014 and held it in 15 quarters. The position peaked at $5.98M in Q4 2015. 242 funds tracked by Wall St. Rank hold PBH as of Q3 2020.

QS Investors reported no remaining Prestige Consumer Healthcare position as of Q3 2020 after selling out during the quarter.
QS Investors sold 1,200 Prestige Consumer Healthcare shares in Q3 2020, an estimated $46K.
QS Investors first reported a position in Prestige Consumer Healthcare in Q4 2014 and held it in 15 quarters.
QS Investors's Prestige Consumer Healthcare position peaked at $5.98M in Q4 2015.
242 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2020.

Based on QS Investors's 13F filing for Q3 2020, filed 12 Nov 2020.